People: Thoratec Corp (THOR.OQ)

THOR.OQ on NASDAQ Stock Exchange Global Select Market

27.27USD
11:21am EDT
Price Change (% chg)

$0.87 (+3.30%)
Prev Close
$26.40
Open
$26.79
Day's High
$27.28
Day's Low
$26.60
Volume
89,790
Avg. Vol
349,599
52-wk High
$43.56
52-wk Low
$22.50

Search Stocks

LaViolette, Paul 

Brief Biography

Mr. Paul A. LaViolette is an Independent Director of Thoratec Corporation. Since January 2011, Mr. LaViolette has been a partner with SV Life Sciences, a venture capital adviser and manager in the life sciences sector, where he was a venture partner from December 2008 until December 2010. Mr. LaViolette was Chief Operating Officer of Boston Scientific Corporation, a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties, from 2004 until 2008 and joined Boston Scientific in January 1994. Prior to becoming its Chief Operating Officer, Mr. LaViolette held positions with Boston Scientific as Senior Vice President and Group President, Cardiovascular for Boston Scientific's Scimed, EPT and Target businesses, President of Scimed, Senior Vice President and Group President-Nonvascular Businesses, and President, Boston Scientific International, and Vice President-International. Prior to joining Boston Scientific, he was employed by C.R. Bard, Inc. in various capacities, including President, U.S.C.I. Division, President, U.S.C.I. Angioplasty Division, Vice President and General Manager, U.S.C.I. Angioplasty Division, and Vice President U.S.C.I. Division. Mr. LaViolette serves as a member of the board of directors of Conceptus, Inc. and TranS1, Inc., as well as a member of the board of directors of several private medical technology companies.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Neil Dimick

--

Taylor Harris

1,210,680

David Lehman

1,293,310

Vasant Padmanabhan

--

D. Keith Grossman

1,404,050

J. Daniel Cole

--
As Of 27 Dec 2013
Search Stocks